New insights on HS phenotypes and treatment response: A post hoc analysis of SUNSHINE and SUNRISE phase 3 trials

被引：0
|
作者：
Passera, Anna [1 ]
Demanse, David [1 ]
Jemec, Gregor B. E. [2 ]
Okoye, Ginette A. [3 ]
Mayo, Tiffany [4 ]
Hsiao, Jennifer [5 ]
Shi, Vivian Y. [6 ]
Porter, Martina J. [7 ,8 ]
Byrd, Angel S. [3 ]
Uhlmann, Lorenz [1 ]
Wei, Xiaoling [9 ]
Vandemeulebroecke, Marc [1 ]
Ravichandran, Shoba [10 ]
Muscianisi, Elisa [10 ]
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Univ Copenhagen, Copenhagen, Denmark
[3] Howard Univ, Coll Med, Washington, DC USA
[4] Univ Alabama Birmingham, Birmingham, AL USA
[5] Univ Southern Calif, Dept Dermatol, Los Angeles, CA USA
[6] Univ Arkansas Med Sci, Little Rock, AR USA
[7] Beth Israel Deaconess Med Ctr, Dept Dermatol, Boston, MA USA
[8] Harvard Med Sch, Dept Dermatol, Boston, MA USA
[9] Novartis Pharmaceut, Shanghai, Peoples R China
[10] Novartis Pharmaceut, E Hanover, NJ USA
来源：
EXPERIMENTAL DERMATOLOGY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [21] STRUCTURAL SEVERITY IN KNEE OSTEOARTHRITIS IMPACTS TREATMENT RESPONSE: A POST HOC POOLED ANALYSIS OF LORECIVIVINT CLINICAL TRIALS
    Yazici, Y.
    Swearingen, C.
    Ghandehari, H.
    Simsek, I.
    Kennedy, S.
    Tambiah, J.
    Mcalindon, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1035 - 1035
  • [22] Structural Severity in Knee Osteoarthritis Impacts Treatment Response: A Post Hoc Pooled Analysis of Lorecivivint Clinical Trials
    Yazici, Yusuf
    Swearingen, Christopher
    Ghandehari, Heli
    Simsek, Ismail
    Kennedy, Sarah
    Tambiah, Jeyanesh
    McAlindon, Timothy
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3759 - 3761
  • [23] STRUCTURAL SEVERITY IN KNEE OSTEOARTHRITIS IMPACTS TREATMENT RESPONSE: A POST HOC POOLED ANALYSIS OF LORECIVIVINT CLINICAL TRIALS
    Yazici, Y.
    Swearingen, C.
    Ghandehari, H.
    Simsek, I.
    Kennedy, S.
    Tambiah, J.
    Mcalindon, T.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S156 - S156
  • [24] Sex- and age-related shift of relapse phenotypes in a cohort of relapsing multiple sclerosis patients: Post hoc analysis from the OPERA phase 3 trials
    Betancourt, A. Leon
    Hoepner, Robert
    Hammer, Helly
    Chan, Andrew
    Salmen, Anke
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (10)
  • [25] Pilocarpine HCl Ophthalmic Solution 1.25% in Mild Presbyopia: Post Hoc Analysis of the GEMINI Phase 3 Trials
    Christie, William
    Kading, David
    Starr, Christopher E.
    O'Dell, Leslie
    Zhang, Zuoyi
    Schachter, Scott
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [26] Efficacy of Sarecycline for Facial Acne Vulgaris in Patients With Skin of Color: Post Hoc Analysis of Phase 3 Trials
    Keri, Jonette
    Harper, Julie
    Baldwin, Hilary
    Graber, Emmy
    Salem, Raidah
    Tomondy, Paul
    Hernandez, Francisco
    Alexis, Andrew
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB43 - AB43
  • [27] Efficacy and Safety of Tofacitinib in Patients with Ankylosing Spondylitis by Baseline BMI: A Post Hoc Analysis of Phase 2 and Phase 3 Trials
    Norton, Hillary
    Sliwinska-Stanczyk, Paula
    Hala, Tomas
    Elzorkany, Bassel
    Stockert, Lori
    Shi, Harry
    Wang, Cunshan
    Paulissen, Jerome
    Ritchlin, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 800 - 803
  • [28] A Post Hoc Analysis of Immunoglobulin Levels in Patients with Relapsing Multiple Sclerosis Treated with Ozanimod in Phase 3 Trials
    Harris, S.
    Southworth, H.
    Sheffield, J. K.
    Maddux, R.
    Cohen, J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 93 - 94
  • [29] Efficacy of IncobotulinumtoxinA for Treatment of Glabellar Frown Lines: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled, Phase 3 Trials
    Jones, Derek
    Carruthers, Jean
    Narins, Rhoda S.
    Coleman, William P., III
    Harrington, Laura
    Brandt, Fredric S.
    Cohen, Joel L.
    DERMATOLOGIC SURGERY, 2014, 40 (07) : 776 - 785
  • [30] Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: a post hoc analysis of the TULIP-1 and TULIP-2 trials
    Bruce, Ian N.
    van Vollenhoven, Ronald F.
    Morand, Eric F.
    Furie, Richard A.
    Manzi, Susan
    White, William B.
    Abreu, Gabriel
    Tummala, Raj
    RHEUMATOLOGY, 2023, 62 (04) : 1526 - 1534
12345